These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9974126)

  • 1. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.
    Basavarajappa BS; Hungund BL
    Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.
    Basavarajappa BS; Hungund BL
    J Neurosci Res; 2001 May; 64(4):429-36. PubMed ID: 11340650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane.
    Basavarajappa BS; Cooper TB; Hungund BL
    Brain Res; 1998 May; 793(1-2):212-8. PubMed ID: 9630633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.
    Griffin G; Atkinson PJ; Showalter VM; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):553-60. PubMed ID: 9580597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
    Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
    Selley DE; Stark S; Sim LJ; Childers SR
    Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.
    Basavarajappa BS; Hungund BL
    J Neurochem; 1999 Feb; 72(2):522-8. PubMed ID: 9930723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
    Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
    Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.
    Sim LJ; Selley DE; Xiao R; Childers SR
    Eur J Pharmacol; 1996 Jun; 307(1):97-105. PubMed ID: 8831110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system.
    Vinod KY; Yalamanchili R; Xie S; Cooper TB; Hungund BL
    Neurochem Int; 2006 Nov; 49(6):619-25. PubMed ID: 16822589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
    Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P
    Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ; Brunk LK; Selley DE
    Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
    Rubino T; Viganò D; Massi P; Parolaro D
    J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.
    Hungund BL; Basavarajappa BS
    Alcohol Alcohol; 2000; 35(2):126-33. PubMed ID: 10787386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
    Petitet F; Jeantaud B; Capet M; Doble A
    Biochem Pharmacol; 1997 Dec; 54(11):1267-70. PubMed ID: 9416978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats.
    Drew LJ; Harris J; Millns PJ; Kendall DA; Chapman V
    Eur J Neurosci; 2000 Jun; 12(6):2079-86. PubMed ID: 10886347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical location of cannabinoid receptors in white matter areas during rat brain development.
    Romero J; Garcia-Palomero E; Berrendero F; Garcia-Gil L; Hernandez ML; Ramos JA; Fernández-Ruiz JJ
    Synapse; 1997 Jul; 26(3):317-23. PubMed ID: 9183820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
    Hosohata Y; Quock RM; Hosohata K; Makriyannis A; Consroe P; Roeske WR; Yamamura HI
    Eur J Pharmacol; 1997 Feb; 321(1):R1-3. PubMed ID: 9083796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.